Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/25/13 → 11/30/15 |
Funding
- Vertex Pharmaceuticals Inc: $2,500.00
Vertex 770-115 An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 years of Age or Younger With Cystic Fibrosis
- Anstead, Michael (PI)